Cargando…

The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions

OBJECTIVES: This study explored the relationship between product trials and consumer demand for alternative nicotine products (ANP). METHODS: An experimental auction was conducted with 258 adult smokers, wherein participants were randomly assigned to one of four experimental conditions. The particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousu, Matthew C., O’Connor, Richard J., Bansal-Travers, Maansi, Pitcavage, James M., Thrasher, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468811/
https://www.ncbi.nlm.nih.gov/pubmed/26063180
http://dx.doi.org/10.1186/s12954-015-0052-3
_version_ 1782376549267275776
author Rousu, Matthew C.
O’Connor, Richard J.
Bansal-Travers, Maansi
Pitcavage, James M.
Thrasher, James F.
author_facet Rousu, Matthew C.
O’Connor, Richard J.
Bansal-Travers, Maansi
Pitcavage, James M.
Thrasher, James F.
author_sort Rousu, Matthew C.
collection PubMed
description OBJECTIVES: This study explored the relationship between product trials and consumer demand for alternative nicotine products (ANP). METHODS: An experimental auction was conducted with 258 adult smokers, wherein participants were randomly assigned to one of four experimental conditions. The participants received the opportunity to try, but did not have to accept, one of three relatively novel ST products (i.e., snus, dissolvable tobacco, or medicinal nicotine), or they were placed into a control group (i.e., no trial). All the participants then bid on all three of these products, as well as on cigarettes. We assessed interest in using ANP based on both trial of the product and bids placed for the products in the experimental auction. RESULTS: Fewer smokers were willing to try snus (44 %) than dissolvable tobacco (64 %) or medicine nicotine (68 %). For snus, we find modest evidence suggesting that willingness to try is associated with greater demand for the product. For dissolvable tobacco or medicinal nicotine, we find no evidence that those who accept the product trial have higher demand for the product. CONCLUSIONS: Free trials of a novel ANP were not strongly associated with product demand, as assessed by willingness to pay. Given the debate over the potential for ANP to reduce the harm from smoking, these results are important in understanding the impact of free trial offers on adoption of ST product as a strategy to reduce harm from tobacco use.
format Online
Article
Text
id pubmed-4468811
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44688112015-06-17 The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions Rousu, Matthew C. O’Connor, Richard J. Bansal-Travers, Maansi Pitcavage, James M. Thrasher, James F. Harm Reduct J Research OBJECTIVES: This study explored the relationship between product trials and consumer demand for alternative nicotine products (ANP). METHODS: An experimental auction was conducted with 258 adult smokers, wherein participants were randomly assigned to one of four experimental conditions. The participants received the opportunity to try, but did not have to accept, one of three relatively novel ST products (i.e., snus, dissolvable tobacco, or medicinal nicotine), or they were placed into a control group (i.e., no trial). All the participants then bid on all three of these products, as well as on cigarettes. We assessed interest in using ANP based on both trial of the product and bids placed for the products in the experimental auction. RESULTS: Fewer smokers were willing to try snus (44 %) than dissolvable tobacco (64 %) or medicine nicotine (68 %). For snus, we find modest evidence suggesting that willingness to try is associated with greater demand for the product. For dissolvable tobacco or medicinal nicotine, we find no evidence that those who accept the product trial have higher demand for the product. CONCLUSIONS: Free trials of a novel ANP were not strongly associated with product demand, as assessed by willingness to pay. Given the debate over the potential for ANP to reduce the harm from smoking, these results are important in understanding the impact of free trial offers on adoption of ST product as a strategy to reduce harm from tobacco use. BioMed Central 2015-06-11 /pmc/articles/PMC4468811/ /pubmed/26063180 http://dx.doi.org/10.1186/s12954-015-0052-3 Text en © Rousu et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Rousu, Matthew C.
O’Connor, Richard J.
Bansal-Travers, Maansi
Pitcavage, James M.
Thrasher, James F.
The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title_full The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title_fullStr The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title_full_unstemmed The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title_short The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
title_sort impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468811/
https://www.ncbi.nlm.nih.gov/pubmed/26063180
http://dx.doi.org/10.1186/s12954-015-0052-3
work_keys_str_mv AT rousumatthewc theimpactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT oconnorrichardj theimpactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT bansaltraversmaansi theimpactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT pitcavagejamesm theimpactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT thrasherjamesf theimpactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT rousumatthewc impactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT oconnorrichardj impactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT bansaltraversmaansi impactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT pitcavagejamesm impactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions
AT thrasherjamesf impactoffreetrialacceptanceondemandforalternativenicotineproductsevidencefromexperimentalauctions